ARTICLE | Company News
Abgenix antibodies, inflammation, cancer news
July 4, 2005 7:00 AM UTC
ABGX restructured and will reduce its headcount by about 15%. The company said it had excess research capacity, and that consolidating its research and preclinical activities into its Burnaby, B.C., f...